Rite Aid Significantly Expands COVID-19 Testing
07 Mai 2020 - 1:15PM
Business Wire
Testing sites will nearly triple with addition
of 46 sites on May 11
Expanded testing criteria includes asymptomatic
adults
Rite Aid (NYSE: RAD) will significantly expand its COVID-19
testing effort with the addition of 46 no-charge testing sites,
most of which will operate through its stores’ drive-through
windows, beginning May 11, 2020. Rite Aid is also expanding
COVID-19 testing criteria at all testing sites to include adults
who are not exhibiting any symptoms of the virus, effective
immediately in accordance with the Centers for Disease Control and
Prevention guidance.
All Rite Aid COVID-19 testing locations utilize self-swab nasal
tests overseen by Rite Aid pharmacists. At all testing locations,
patients are required to provide government issued identification,
be at least 18 years old, and need to pre-register online at
www.riteaid.com in order to schedule a time slot for testing.
Rite Aid will now operate 71 testing sites across twelve states
through its partnership with the U.S. Department of Health and
Human Services (HHS). Rite Aid's self-testing parking lot sites are
open from 9 a.m. – 5 p.m. seven days a week. Rite Aid testing
locations operating through its stores’ drive-through windows are
open Monday through Friday 10 a.m. – 8 p.m. and Saturday and Sunday
10 a.m. – 5 p.m. Rite Aid has the capacity to conduct up to 10,000
tests daily across all locations through online appointments.
“Rite Aid has been at the forefront of helping our nation scale
up COVID-19 testing capabilities, and we’re proud to announce the
addition of 46 new testing sites,” said Jim Peters, chief operating
officer, Rite Aid. “Opening testing to asymptomatic individuals, as
well as providing more locations using our drive-through window,
represent important milestones in our response to the pandemic. We
remain grateful for the daily efforts and sacrifices of our
front-line associates who make the continued expansion of our
testing possible.”
A complete list of Rite Aid’s COVID-19 testing sites can be seen
at www.riteaid.com.
Rite Aid has partnered with Verily and will use its Baseline
COVID-19 Program to provide screening, scheduling and return of
results to participants for Rite Aid testing sites.
Rite Aid also selected BioReference Laboratories to provide
COVID-19 laboratory testing to all drive-up locations with the goal
of flattening the curve through accessible diagnostic testing.
Clinical oversight for the COVID-19 testing program is provided
by PWNHealth, a national clinician network that enables safe and
easy access to diagnostic testing.
Rite Aid will continue to provide regular updates on the
company's progress with COVID-19 testing.
About Rite Aid Corporation
Rite Aid Corporation is on the front lines of delivering
healthcare services and retail products to more than 1.6 million
Americans daily. Our pharmacists are uniquely positioned to engage
with customers and improve their health outcomes. We provide an
array of whole being health products and services for the entire
family through over 2,400 retail pharmacy locations across 18
states. Through EnvisionRxOptions, we provide pharmacy benefits and
services to approximately 4 million members nationwide. For more
information, www.riteaid.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200507005486/en/
MEDIA: Chris Savarese 717-975-5718
christopher.savarese@riteaid.com
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
Rite Aid (NYSE:RAD)
Historical Stock Chart
Von Apr 2023 bis Apr 2024